By LabPulse.com staff writers
July 9, 2020 — Applied DNA Sciences has created Applied DNA Clinical Labs (ADCL), a wholly owned subsidiary focused on the commercial development of the company’s oncology and virology test kits.
ADCL’s area of focus will encompass its Linea reverse transcription polymerase chain reaction (RT-PCR) test kits for COVID-19, which received emergency use authorization (EUA) in May. It will also include the company’s liquid biopsy oncology platform, which detects and enumerates invasive circulating tumor cells in cancer patients.
